[Minutes, Advisory Committee to the Director GP-160 Meeting (1992: Bethesda, Maryland)]

1 MR. VOLVOVITZ: I don't think I've
2 misinterpreted, Larry. My point is your data has not
3 been replicated as carefully as studies involving (Off
4 mike.). And by selecting only one or two successes
5 out of many, many immunizations, that was very
6 misleading.
7 And all I am saying is please try to
8 provide objective and open data. Show all of the
9 data. Don't select one or two things that support one
10 position and ignore data that sometimes are double
11 blind placebo-controlled studies.
12 I heard Dan in Amsterdam say that, above
13 all, what is important are double blind
14 placebo-controlled studies. And that's what we're
15 asking for. Please try to provide the data without
16 bias so people can see everything that's there.
17 CO-CHAIRMAN FAUCI: Jesse?
18 MR. DOBSON: I think if anyone is going to
19 talk about presenting all of the data, you have come
20 under question as well. I just want to point out that
21 there may be perhaps some bias in the president of the
22 company interpreting his own data.
NEAL R. GROSS
COURT REPORTERS AND TRANSCRIBERS
1323 RHOOE ISLAND AVENUE, N.W.
[phone] WASHINGTON, D.C. 20005 [phone]